The paper is unclear on the heparin exclusion. It says:
“The exclusion criteria were, among others… treatment with heparin exceeding 10,000 IU/day low-molecular-weight heparin…”<
What’s unclear is what eligibility restriction, if any, was placed on prior use of unfractionated heparin.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”